LBA57 MHC-II antigen presentation pathway as a predictive biomarker for sintilimab plus chemotherapy in first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer (nsq-NSCLC).

Authors :: Yang, Y.
Sun, J.
Wang, Z.
Fang, J.
Yu, Q.
Han, B.
Cang, S.
Chen, G.
Mei, X.
Yang, Z.
Ma, R.
Bi, M.
Ren, X.
Zhou, J.
Li, B.
Zhou, H.
Wang, S.
Xu, W.
Peng, B.
Zhang, L.
Source :: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS1186-S1186. 1p.
Publication Year :: 2020

Subjects :: *NON-small-cell lung carcinoma
*ANTIGEN presentation
*BIOMARKERS
*CANCER chemotherapy
*METASTASIS

Full Text Access

Tools